This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Université Pierre Et Marie Curie (Paris Vi). Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2005
Title: Françoise Russo-Marie: Innovator in Chemical Structures
Introduction
Françoise Russo-Marie is a notable inventor based in Sèvres, France. He has made significant contributions to the field of chemical structures, particularly those with an affinity for phospholipids. His work has implications in both diagnostics and pharmaceuticals.
Latest Patents
Russo-Marie holds a patent for a chemical structure that has an affinity for a negatively charged phospholipid. This patent includes a labeling compound diagnostic kit and a drug that comprises this structure. The invention is designed for the specific recognition of lipid vectors, which can be crucial in various biomedical applications. The compound is particularly useful for recognizing and sequestering negatively charged lipids, such as phosphatidyl-serine and phosphatidic acid. He has been granted 1 patent for this innovative work.
Career Highlights
Throughout his career, Françoise Russo-Marie has worked with prominent organizations, including the Commissariat à l'Énergie Atomique and Université Pierre et Marie Curie (Paris VI). His experience in these institutions has allowed him to develop his expertise in chemical structures and their applications.
Collaborations
Russo-Marie has collaborated with notable colleagues, including Alain Sanson and Jean-Michel Neumann. These partnerships have contributed to the advancement of his research and innovations in the field.
Conclusion
Françoise Russo-Marie's work in chemical structures demonstrates his commitment to advancing scientific knowledge and practical applications in the field of biochemistry. His innovative patent reflects the potential for significant advancements in diagnostics and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile